Selective aggregation of PAMAM dendrimer nanocarriers and PAMAM/ZnPc nanodrugs on human atheromatous carotid tissues: a photodynamic therapy for atherosclerosis

Nanoscale Research Letters

Volumn 10, Issue 1, 2015, Pages

  Spyropoulos Antonakakis, Nikolaos ^a   Sarantopoulou, Evangelia ^a   Trohopoulos, Panagiotis N ^b   Stefi, Aikaterina L ^a   Kollia, Zoe ^a   Gavriil, Vassilios E ^a   Bourkoula, Athanasia ^c   Petrou, Panagiota S ^c   Kakabakos, Sotirios ^c   Semashko, Vadim V ^d   Nizamutdinov, Alexey S ^d   Cefalas, Alkiviadis Constantinos ^a,d  

^a THEORETICAL AND PHYSICAL CHEMISTRY INSTITUTE   (Greece)

^b CosmoPhosLtd ^*  (Greece)

^c INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^d KAZAN FEDERAL UNIVERSITY   (Russian Federation)

Author keywords

AFM; Atheromatous plaque; Biosurfaces; Cardiovascular; Dendrimers; Fractal analysis; Nanodrugs; Nanoparticle aggregation; Photodynamic therapy; Surface roughness parameters

Indexed keywords

ATOMIC FORCE MICROSCOPY; CELL DEATH; CONTROLLED DRUG DELIVERY; DENDRIMERS; DEPOSITION; DISEASES; ENDOTHELIAL CELLS; FRACTALS; HISTOLOGY; MOLECULAR OXYGEN; MOLECULES; NANOPARTICLES; PHOTOSENSITIZERS; SURFACE ROUGHNESS; TARGETED DRUG DELIVERY; TEXTURES; TISSUE;

ATHEROMATOUS PLAQUE; BIO-SURFACES; CARDIOVASCULAR; FRACTAL ANALYSIS; NANODRUGS; NANOPARTICLE AGGREGATION; SURFACE ROUGHNESS PARAMETERS;

PHOTODYNAMIC THERAPY;

EID: 84929207019     PISSN: 19317573     EISSN: 1556276X     Source Type: Journal    
DOI: 10.1186/s11671-015-0904-5     Document Type: Article

References (85)

1. Cicha I, Lyer S, Alexiou C, Garlichs CD. Nanomedicine in diagnostics and therapy of cardiovascular diseases: beyond atherosclerotic plaque imaging. Nanotechnol Rev. 2013;2:449–72.
2. Whitesides GM. The ‘right’ size in nanobiotechnology. Nat Biotechnol. 2003;21:1161–5.
3. Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based bio-barcodes for the ultrasensitive detection of proteins. Science. 2003;301:1884–6.
4. Tsapis N, Bennett D, Jackson B, Weitz DA, Edwards DA. Trojan particles: large porous carriers of nanoparticles for drug delivery. Proc Natl Acad Sci U S A. 2002;99:12001–5.
5. Jeong W, Kim MJ, Rhee K. Computational study of particle size effects on selective binding of nanoparticles in arterial stenosis. Comput Biol Med. 2013;43:417–24.
6. Libby P, Ridker PM, Hansso GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.
7. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nature. 2010;10:36–46.
8. Peng C, Li Y, Liang H, Cheng J, Li Q, Sun X, et al. Detection and photodynamic therapy of inflamed atherosclerotic plaques in the carotid artery of rabbits. J Photochem and Photobiol B: Biology. 2011;102:26–31.
9. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer. 2003;3:380–7.
10. Chatterjee DK, Fong LS, Zhang Y. Nanoparticles in photodynamic therapy: an emerging paradigm. Adv Drug Deliv Rev. 2008;60:1627–37.
11. Kim J, Santos OA, Park JH. Selective photosensitizer delivery into plasma membrane for effective photodynamic therapy. J Control Release. 2014;191:98–104.
12. Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: A review of current status and future prospects. Nano Today. 2014;9:223–43.
13. de Vries HE, Moor AC, Dubbelman TM, van Berkel TJ, Kuiper J. Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. J Pharmacol Exp Ther. 1999;289:528–34.
14. McCarthy JR, Korngold E, Weissleder R, Jaffer FA. A light-activated theranostic nanoagent for targeted macrophage ablation in inflammatory atherosclerosis. Small. 2010;6:2041–9.
15. Choi Y, McCarthy JR, Weissleder R, Tung C-H. Conjugation of a photosensitizer to an oligoarginine-based cell-penetrating peptide increases the efficacy of photodynamic therapy. Chem Med Chem. 2006;1:458–63.
16. McCarthy JR, Weissleder R. Model systems for fluorescence and singlet oxygen quenching by metalloporphyrins. Chem Med Chem. 2007;2:360–5.
17. McCarthy JR, Jaffer FA, Weissleder R. Macrophage-targeted theranostic nanoparticle for biomedical applications. Small. 2006;2:983–7.
18. Wang A, Long L, Zhang C. Synthesis and properties of photo-activable phthalocyanines: a brief overview. J Inclusion Phenom Macrocyclic Chem. 2011;71:1–24.
19. Chen Z, Xu P, Chen J, Chen H, Hu P, Chen X, et al. Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy. Acta Biomater. 2014;10:4257–68.
20. Liu W, Jensen TJ, Fronczek FR, Hammer RP, Smith KM, Vicente MG. Synthesis and cellular studies of non aggregated water-soluble phthalocyanines. J Med Chem. 2005;48:1033–41.
21. Konan YN, Gurny R, Allémann E. State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B. 2002;66:89–106.
22. Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. J Am Chem Soc. 2003;125:7860–5.
23. Brasch M, de la Escosura A, Ma Y, Uetrecht C, Heck AJ, Torres T, et al. Encapsulation of phthalocyanine supramolecular stacks into virus-like particles. J Am Chem Soc. 2011;133:6878–81.
24. Mitsunaga M, Ogawa M, Kosaka N, Rosenblum LT, Choyke PL, Kobayashi H. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules. Nat Med. 2010;17:1685–91.
25. Nishiyama N, Morimoto Y, Jang WD, Kataoka K. Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv Drug Deliv Rev. 2009;61:327–38.
26. Pang X, Yang X, Zhai G. Polymer-drug conjugates: recent progress on administration routes. Expert Opin Drug Deliv. 2014;11:1075–86.
27. Mojzisova H, Bonneau S, Brault D. Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells. EurBiophys J. 2007;36:943–53.
28. Stefi AL, Sarantopoulou E, Kollia Z, Spyropoylos-Antonakakis N, Bourkoula A, Petrou PS, et al. Nanothermodynamics mediates drug delivery. Adv Exp Med Biol. 2015;822:213–30.
29. Dement’eva OV, Vinogradova MM, Luk’yanets EA, Solov’eva LI, Ogarev VA, Rudoy VM. Zinc phthalocyanine-based water-soluble thiolated photosensitizer and its conjugates with gold nanoparticles: synthesis and spectral properties. Colloid J. 2014;76:539–45.
30. da Volta SM, Oliveira MR, dos Santos EP, de BritoGitirana L, Barbosa GM, Quaresma CH, et al. Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells. Int J Nanomedicine. 2011;6:227–38.
31. Liang R, Tian R, Ma L, Zhang L, Hu Y, Wang J, et al. A supermolecular photosensitizer with excellent anticancer performance in photodynamic therapy. Adv Funct Mater. 2014;24:3144–51.
32. Shang T, Wang CD, Ren L, Tian XH, Li DH, Ke XB, et al. Synthesis and characterization of NIR-responsive Aurod@pNIPAAm-PEGMA nanogels as vehicles for delivery of photodynamic therapy agents. Nanoscale Res Lett. 2013;8:4.
33. Ricci-Junior E, Marchetti JM. Zinc (II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int J Pharm. 2006;310:187–95.
34. Conte C, Ungaro F, Maglio G, Tirino P, Siracusano G, Sciortino MT, et al. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn (II)-phthalocyanine inspired by combination therapy for cancer. J Control Release. 2013;167:40–52.
35. Li L, Luo Z, Chen Z, Chen J, Zhou S, Xu P, et al. Enhanced photodynamic efficacy of zinc phthalocyanine by conjugating to heptalysine. Bioconjug Chem. 2012;23:2168–72.
36. Tu J, Wang T, Shi W, Wu G, Tian X, Wang Y, et al. Multifunctional ZnPc-loaded mesoporous silica nanoparticles for enhancement of photodynamic therapy efficacy by endolysosomal escape. Biomaterials. 2012;33:7903–14.
37. Abbasi E, Aval SF, Akbarzadeh A, Milani M, Nasrabadi HT, Joo SW, et al. Dendrimers: synthesis, applications, and properties. Nanoscale Res Lett. 2014;9:247.
38. Lu HL, Syu WJ, Nishiyama N, Kataoka K, Lai PS. Dendrimer phthalocyanine-encapsulated polymeric micelle-mediated photochemical internalization extends the efficacy of photodynamic therapy and overcomes drug-resistance in vivo. J Control Release. 2011;155:458–64.
39. Shcharbin D, Janaszewska A, Klajnert-Maculewicz B, Ziemba B, Dzmitruk V, Halets I, et al. How to study dendrimers and dendriplexes III. Biodistribution pharmacokinetics and toxicity in vivo. J Control Release. 2014;181:40–52.
40. Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S, et al. A new class of polymers: starburst-dendritic macromolecules. Polym J. 1985;17:117–32.
41. Kannan RM, Nance E, Kannan S, Tomalia DA. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J Int Med. 2014;276:579–617.
42. Tomalia DA, Christensen JB, Baos U. Dendrimers, dendrons, and dendritic polymers: discovery, applications, and the future. New York: Cambridge University Press; 2012.
43. Pourianazar NT, Mutlu P, Gunduz U. Bioapplications of poly (amidoamine) (PAMAM) dendrimers in nanomedicine. J Nanopart Res. 2014;16:2342.
44. Svenson S, Tomalia DA. Dendrimers in biomedical applications—reflections on the field. Adv Drug Del Rev. 2005;57:2106–29.
45. Gupta AS. Nanomedicine approaches in vascular disease: a review. Nanomedicine. 2011;7:763–79.
46. Caminade AM, Turrin CO. Dendrimers for drug delivery. J Mater Chem B. 2014;2:4055–66.
47. Mammen M, Choi SK, Whitesides GM. Polyvalent interactions in biological systems: implications for design and use of multivalent ligands and inhibitors. Angew Chem Int Ed. 1998;37:2754–94.
48. 2 laser using an oscillator amplifier configuration. Appl Phys B-Lasers Opt. 1990;51:141–5.
49. 2 laser. J Mod Opt. 1990;37:501–9.
50. Cefalas AC. Current trends in 157 nm dry lithography. Appl Surf Sci. 2005;247:577–83.
51. Douvas AM, Petrou PS, Kakabakos SE, Misiakos K, Argitis P, Sarantopoulou E, et al. 157-nm laser ablation of polymeric layers for fabrication of biomolecule microarrays. Anal Bioanal Chem. 2005;381:1027–32.
52. Cefalas AC, Argitis P, Kollia Z, Sarantopoulou E, Ford TW, Stead AD, et al. Laser plasma x-ray contact microscopy of living specimens using a chemically amplified epoxy resist. Appl Phys Lett. 1998;72:3258–60.
53. Horcas I, Fernández R, Gómez-Rodríguez JM, Colchero J, Gómez-Herrero J, Baro AM. WSXM: a software for scanning probe microscopy and a tool for nanotechnology. Rev Sci Instrum. 2007;78:013705.
54. Niu L, Qian M, Yang W, Meng L, Xiao Y, Wong KKL, et al. Surface roughness detection of arteries via texture analysis of ultrasound images for early diagnosis of atherosclerosis. Plos One. 2013;8:e76880.
55. Mandelbrot BB. The fractal geometry of nature. New York: Freeman; 1983.
56. Zmeskal O, Dzik P, Vesely M. Entropy of fractal systems. Comput Math Appl. 2013;66:135–46.
57. Popescu DP, Flueraru C, Mao Y, Chang S, Sowa MG. Signal attenuation and box-counting fractal analysis of optical coherence tomography images of arterial tissue. Biomed Opt Express. 2010;1:268–77.
58. Di Giovanni P, Ahearn TS, Semple SI, Lovell LM, Miller I, Gilbert FJ, et al. The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy. Breast Cancer Res Treat. 2012;133:1199–206.
59. Katsaloulis P, Verganelakis DA, Provata A. Fractal dimension and lacunarity of tractography images of the human brain. Fractals. 2009;17:181–9.
60. Asvestas P, Golemati S, Matsopoulos GK, Nikita KS, Nicolaides AN. Fractal dimension estimation of carotid atherosclerotic plaques from b-mode ultrasound: a pilot study. Ultrasound Med Biol. 2002;28:1129–36.
61. Rakebrandt F, Crawford DC, Havard D, Coleman D, Woodcock JP. Relationship between ultrasound texture classification images and histology of atherosclerotic plaque. Ultrasound Med Biol. 2000;26:1393–402.
62. Krasowska M, Grzywna ZJ, Mycielska ME, Djamgoz MB. Fractal analysis and ionic dependence of endocytotic membrane activity of human breast cancer cells. Eur Biophys J. 2009;38:1115–25.
63. Fuseler JW, Millette CF, Davis JM, Carver W. Fractal and image analysis of morphological changes in the actin cytoskeleton of neonatal cardiac fibroblasts in response to mechanical stretch. Microsc Microanal. 2007;13:133–43.
64. Bitler A, Dover R, Shai Y. Fractal properties of macrophage membrane studied by AFM. Micron. 2012;43:1239–45.
65. Salerno M, Giacomelli L, Derchi G, Patra N, Diaspro A. Atomic force microscopy in vitro study of surface roughness and fractal character of a dental restoration composite after air-polishing. Biomed Eng Online. 2010;9:59.
66. Něcas D, Klapetek P. Gwyddion: an open-source software for SPM data analysis. Cent Eur J Phys. 2012;10:181–8.
67. Mannelquist A, Almqvist N, Fredriksson S. Influence of tip geometry on fractal analysis of atomic force microscopy images. Appl Phys A. 1998;66:S891–5.
68. Smith RL, Mecholsky Jr JJ. Application of atomic force microscopy in determining the fractal dimension of the mirror, mist, and hackle region of silica glass. Mater Charact. 2011;62:457–62.
69. Lillehei PT, Kim JW, Gibbons LJ, Park C. A quantitative assessment of carbon nanotube dispersion in polymer matrices. Nanotechnology. 2009;20:325708.
70. Mecke KR. Morphological characterization of patterns in reaction–diffusion systems. Phys Rev E. 1996;53:4794–800.
71. Michielsen K, De Raedt H. Integral-geometry morphological image analysis. Phys Rep. 2001;347:461–538.
72. Lobatto ME, Fuster V, Fayad ZA, Mulder WJ. Perspectives and opportunities for nanomedicine in the management of atherosclerosis. Nat Rev Drug Discov. 2011;10:835–52.
73. Jiang W, Kim BYS, Rutka JT, Chan WCW. Nanoparticle-mediated cellular response is size-dependent. Nat Nanotechnol. 2008;3:145–50.
74. Mecke A, Lee I, Baker Jr JR, Holl MM, Orr BG. Deformability of poly (amidoamine) dendrimers. Eur Phys J E Soft Matter. 2004;14:7–16.
75. Cahill BP, Papastavrou G, Koper GJ, Borkovec M. Adsorption of poly (amido amine) (PAMAM) dendrimers on silica: importance of electrostatic three-body attraction. Langmuir. 2008;24:465–73.
76. Li J, Piehler LT, Qin D, Baker Jr JR, Tomalia DA, Meier DJ. Visualization and characterization of poly (amidoamine) dendrimers by atomic force microscopy. Langmuir. 2000;16:5613–6.
77. Yu L, Zhang P, Yang H, Yang G, Zhang J, Wang J. Aggregation behaviors of novel amphiphilic dendrimers at solid–liquid interface. J Dispersion Sci Technol. 2014;35:456–62.
78. Müller T, Yablon DG, Karchner R, Knapp D, Kleinman MH, Fang H, et al. AFM studies of high-generation PAMAM dendrimers at the liquid/solid interface. Langmuir. 2002;18:7452–5.
79. Dobrovolskaia MA, Patri AK, Simak J, Hall JB, Semberova J, de Paoli Lacerda SH, et al. Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro. Mol Pharm. 2012;9:382–93.
80. Hemmer R, Hall A, Spaulding R, Rossow B, Hester M, Caroway M, et al. Analysis of biotinylated generation 4 poly (amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood–brain barrier. Molecules. 2013;18:11537–52.
81. Kitchens KM, El-Sayed ME, Ghandehari H. Transepithelial and endothelial transport of poly (amidoamine) dendrimers. Adv Drug Deliv Rev. 2005;57:2163–76.
82. Markowicz-Piasecka M, Łuczak E, Chałubiński M, Broncel M, Mikiciuk-Olasik E, Sikora J. Studies towards biocompatibility of PAMAM dendrimers–overall hemostasis potential and integrity of the human aortic endothelial barrier. Int J Pharm. 2014;473:158–69.
83. Cefalas AC, Sarantopoulou E, Kollia Z, Kitsara M, Raptis I, Bakalis E. Entropic Nanothermodynamic potential from molecular trapping within photon induced nano-voids in photon processed PDMS layers. Soft Matt. 2012;8:5561–73.
84. Ye K, Qin J, Peng Z, Yang X, Huang L, Yuan F, et al. Polyethylene glycol-modified dendrimer-entrapped gold nanoparticles enhance CT imaging of blood pool in atherosclerotic mice. Nanoscale Res Lett. 2014;9:529–41.
85. Kim Y, Kwak Y, Chang R. Free energy of PAMAM dendrimer adsorption onto model biological membrane. J Phys Chem B. 2014;118:6792–802.